Goldshleger Ilya's Form 4 filing
RxSight, Inc. (RXST) · filed Dec 20, 2023
- Accession no.
- 0001209191-23-059385
- Filed
- Dec 20, 2023
- Trade date
- Dec 18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $426.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldshleger IlyaCIK 0001874147 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Common Stock | MOption exerciseAcquired | +937 | $4.13 | +$3,869.81 | 27,412 | Direct | |
| Dec 18, 2023 | Common Stock | MOption exerciseAcquired | +10,000 | $15.08 | +$150,800 | 37,412 | Direct | |
| Dec 18, 2023 | Common Stock | SSaleDisposed | −937 | $38.99F2 | −$36,533.63 | 36,475 | Direct | |
| Dec 18, 2023 | Common Stock | SSaleDisposed | −4,894 | $38.93F3 | −$190,523.42 | 31,581 | Direct | |
| Dec 18, 2023 | Common Stock | SSaleDisposed | −106 | $39.45 | −$4,181.7 | 31,475 | Direct | |
| Dec 18, 2023 | Common Stock | SSaleDisposed | −5,000 | $39.09F4 | −$195,450 | 26,475 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Common Stock | MOption exerciseDisposed | −937 | $0.00 | $0 | 20,843 | Direct | |
| Dec 18, 2023 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 135,207 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 937 shares sold in the price range of $38.45 to $39.45 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 4,894 shares sold in the price range of $38.41 to $39.39 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $39.00 to $39.45 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.